组织陈列-产品详情

home > TISSUE ARRAYS > Baldder > UBD721

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

72

CASES:

24

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

8

Column number:

9

Tissue Array Type:

FFPE

Species:

Human

UBD721

$225.00

Description: Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores

Details: Bladder carcinoma tissue array with adjacent normal tissue, containing 18 cases of urothelial carcinoma, 6 adjacent normal bladder tissue, triplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

72 Cores 24 Cases Baldder Matched or Unmatched triplicate cores per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Inflammation(*)
Malignant(I)
Malignant(II)
Malignant(IIIA)
_ma

TISSUE ARRAYS
UBD721

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

UBD721

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size
A1	1	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	43.53.5
A2	2	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	43.53.5
A3	3	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	43.53.5
A4	4	58	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
A5	5	58	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
A6	6	58	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
A7	7	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
A8	8	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
A9	9	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
B1	10	70	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	432
B2	11	70	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	432
B3	12	70	M	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	432
B4	13	69	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	331.5
B5	14	69	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	331.5
B6	15	69	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	331.5
B7	16	54	M	Bladder	Low-grade urothelial carcinoma	*	T2aN0M0	II	Malignant	110.5
B8	17	54	M	Bladder	Low-grade urothelial carcinoma	*	T2aN0M0	II	Malignant	110.5
B9	18	54	M	Bladder	Low-grade urothelial carcinoma	*	T2aN0M0	II	Malignant	110.5
C1	19	76	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
C2	20	76	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
C3	21	76	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
C4	22	66	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	543
C5	23	66	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	543
C6	24	66	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	543
C7	25	54	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	220.6
C8	26	54	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	220.6
C9	27	54	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	220.6
D1	28	46	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	21.51
D2	29	46	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	21.51
D3	30	46	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	21.51
D4	31	67	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	551.5
D5	32	67	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	551.5
D6	33	67	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	551.5
D7	34	82	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
D8	35	82	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
D9	36	82	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
E1	37	50	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	743
E2	38	50	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	743
E3	39	50	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	743
E4	40	60	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	*
E5	41	60	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	*
E6	42	60	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	*
E7	43	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
E8	44	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
E9	45	68	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	*
F1	46	61	M	Bladder	High grade urothelial carcinoma (sparse)	*	T3N0M0	IIIA	Malignant	*
F2	47	61	M	Bladder	High grade urothelial carcinoma (sparse)	*	T3N0M0	IIIA	Malignant	*
F3	48	61	M	Bladder	High grade urothelial carcinoma (sparse)	*	T3N0M0	IIIA	Malignant	*
F4	49	74	F	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
F5	50	74	F	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
F6	51	74	F	Bladder	High grade urothelial carcinoma (sparse)	*	T2bN0M0	II	Malignant	*
F7	52	48	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
F8	53	48	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
F9	54	48	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
G1	55	67	M	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
G2	56	67	M	Bladder	Chronic inflammation	*	*	*	Inflammation	*
G3	57	67	M	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
G4	58	46	F	Bladder	Chronic inflammation	*	*	*	Inflammation	*
G5	59	46	F	Bladder	Chronic inflammation	*	*	*	Inflammation	*
G6	60	46	F	Bladder	Chronic inflammation	*	*	*	Inflammation	*
G7	61	78	F	Bladder	Chronic inflammation	*	*	*	Inflammation	*
G8	62	78	F	Bladder	Chronic inflammation	*	*	*	Inflammation	*
G9	63	78	F	Bladder	Chronic inflammation	*	*	*	Inflammation	*
H1	64	51	M	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
H2	65	51	M	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
H3	66	51	M	Bladder	Chronic inflammation	*	*	*	Inflammation	*
H4	67	73	M	Bladder	Chronic inflammation	*	*	*	Inflammation	*
H5	68	73	M	Bladder	Chronic inflammation	*	*	*	Inflammation	*
H6	69	73	M	Bladder	Chronic inflammation	*	*	*	Inflammation	*
H7	70	49	F	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
H8	71	49	F	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
H9	72	49	F	Bladder	Chronic inflammation with hyperplasia and squamous metaplasia	*	*	*	Inflammation	*
_marker_

Find overlapping cases with this tissue array:

UBD721

File Format: .xlsx

Release Date: 2025-01-17 16:11:46
Download

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma